A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Levetiracetam dry syrup at doses up to 60 mg/kg/day or
3000 mg/day used as adjunctive therapy in Japanese pediatric patients aged ≥4 to <16 years
with uncontrolled Generalized Tonic-Clonic (GTC) seizures despite treatment with 1 or 2
Anti-Epileptic Drugs (AEDs).